67
Participants
Start Date
March 31, 2011
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
N-Acetylcysteine
All eligible study subjects will be treated with 600mg of N-Acetylcysteine orally twice a day for 2 weeks, then the dose will be increased to 1200mg twice a day for two weeks, and to 1800mg twice a day for 4 weeks.
fMRI
All eligible subjects and controls will undergo an emotional face-viewing task in our fMRI paradigm in order to focus in on the circuitry related to affect processing.
University of Minnesota Dept. of Psychiatry Ambulatory Research Center, Minneapolis
Collaborators (1)
Minnesota Medical Foundation
OTHER
University of Minnesota
OTHER